5 Sept 20252cites
Grafting of Resveratrol-Chitosan Nanoparticles as a Promising Radiosensitizer and Protector in DMBA-Induced Breast Cancer in MicePublisher siteCurrent Cancer Drug Targets, Sirtuins and Resveratrol in Medicine
Active, last published 2026
2
H-index
5
Citations
Azza has not officially claimed their profile. If you are Azza, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Azza M. Metwaly will appear here once their profile is updated.
02 · Reach
Publication output and reach
Azza's work has been cited 5 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Sadat City, EgyptDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
3 works13 May 20252cites
Optimization of Hesperidin Nanoparticles as a Promising CYP2E1 and CYP3A11 Regulator in Paracetamol-Intoxicated MicePublisher siteCurrent Pharmaceutical Biotechnology, Phytochemicals and Antioxidant Activities
17 Dec 2024Open access1cites
Phloretin-nanospanlastics for targeting the Akt/PI3K signaling pathways in dimethylhydrazine-induced colon cancer in micePublisher siteInternational Journal of Pharmaceutics X, Polymer Science and PVC
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Azza?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you